Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004952316 | SCV005450535 | uncertain significance | Inborn genetic diseases | 2024-08-04 | criteria provided, single submitter | clinical testing | The c.22A>C (p.M8L) alteration is located in exon 1 (coding exon 1) of the MPL gene. This alteration results from a A to C substitution at nucleotide position 22, causing the methionine (M) at amino acid position 8 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |